NCT04704921 · Interventional trial
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
Overall registry status Active not recruiting
Phase 2 · Phase 3
Conditions AMD, CNV, Choroidal Neovascularization, Neovascular AMD, Neovascular Age-related Macular Degeneration, Wet AMD, Wet Age-related Macular Degeneration, nAMD, wAMD
Delaware Valley sites
- Mid Atlantic Retina /ID# 256013 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory